CSIMarket Company Name, Ticker, Industry, else..
 
Tempus Ai Inc   (NASDAQ: TEM)
 
Price: $63.0500 $-0.99 -1.546%
Day's High: $64.55000305175781 Week Perf: -8.26 %
Day's Low: $ 60.58 30 Day Perf: 43.72 %
Volume (M): 7,149,896 52 Wk High: $ 104.32
Volume (M$): $ 0 52 Wk Avg: $62.41
Open: $62.37 52 Wk Low: $40.77



 Market Capitalization (Millions $) 11
 Shares Outstanding (Millions) 0
 Employees 3,800
 Revenues (TTM) (Millions $) 1,364
 Net Income (TTM) (Millions $) -303
 Cash Flow (TTM) (Millions $) 373
 Capital Exp. (TTM) (Millions $) 34

Business Description


The company operates in the healthcare and biotechnology sector, specializing in cancer treatment through molecular data and targeted oncology therapeutics. It develops and commercializes products and services related to genomic data analysis, including Intelligent Diagnostics. The company seeks to expand its focus beyond oncology into additional disease areas and geographic markets. It also pursues growth through acquisitions and joint ventures to enhance its product portfolio.


   Company Address: 600 West Chicago Avenue Chicago 60654 IL
   Company Phone Number: 976-5448   Stock Exchange / Ticker: NASDAQ TEM


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Business Update

Breaking New Ground How Tempus Revolutionary RNA-Based Device is Shaping the Future of Precision Medicine

Published Mon, Sep 22 2025 12:54 PM UTC

In a landmark achievement, Tempus AI, Inc. (NASDAQ: TEM) has secured a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its novel RNA-based Tempus xR IVD device. This development holds significant implications not only for the company but also for the broader landscape of precision medicine and drug development. As a frontrunner in adopting artificial in...
Business Update

Tempus AI to Spotlight AI Innovations in Precision Medicine at Morgan Stanley Healthcare Conference,

Published Thu, Sep 4 2025 3:16 AM UTC

Tempus AI Set to Showcase Precision Medicine Innovations at Morgan Stanley s 23rd Annual Global Healthcare Conference Tempus AI, Inc. (NASDAQ: TEM), a pioneering technology company leading the charge in artificial intelligence (AI) to revolutionize precision medicine and patient care, is preparing to make waves at the upcoming Morgan Stanley 23rd Annual Global Healthcare Con...
Announcement

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Acti...

Published Thu, Jul 10 2025 5:08 PM UTC

Investor Alert: Tempus AI, Inc. Faces Class Action Lawsuit Amid Investor LossesIn a significant development for shareholders of Tempus AI, Inc. (NASDAQ: TEM), the Pomerantz Law Firm has announced the initiation of a class action lawsuit against the company, marking an escalating concern over the firm’s performance and disclosure practices. This lawsuit serves as a crucial...
Business Update

Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry

Published Mon, May 5 2025 3:08 PM UTC

Leveraging AI in Psychiatry: Tempus Notetaker Revolutionizes Clinical DocumentationIn a significant leap for mental health care, Tempus AI, Inc. has unveiled its latest innovation, Notetaker, an artificial intelligence-driven clinical assistant designed to foster efficiency and enhance precision in psychiatric practice. As mental health professionals grapple with the chall...
Business Update

Tempus AI Charts New Course in Cancer Care with Elite Physician Advisory Board,

Published Sun, Apr 20 2025 6:24 AM UTC

Tempus AI Enlists Top Physicians to Revolutionize Oncology Research with New Advisory Board Tempus AI, Inc. (NASDAQ: TEM), a Chicago-based leader in AI-driven precision medicine, has made a significant stride in advancing oncology research through the establishment of a distinguished advisory board. This move marks a pivotal moment as the company continues to forge a path to...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.01
Price to Sales (Expected) -
Price to Book 0.03
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.64
Working Capital Ratio 3.31
Leverage Ratio (MRQ) 4.13
Total Debt to Equity 0.97
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -312.25 $
Revenues (TTM) 7621.05 $
Cash Flow (TTM) 2081.22 $
Cash 2911.56 $
Book Value 2326.28 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 358,992
Net Income per Employee (TTM) -79,713
Receivable Turnover Ratio (TTM) 4.67
Inventory Turnover Ratio (TTM) 7.81
Asset Turnover Ratio (TTM) 0.66

Profitability Ratios Current
Gross Margin (MRQ) 71 %
Operating Margin (MRQ) -24.33 %
Net Margin (MRQ) -36.17 %
Net Cash Flow Margin (MRQ) -24.01 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Tempus Ai Inc's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.